Real-World Two-Year Weight Loss Outcomes With Breath Biofeedback
Real-World Durability of Weight Loss With a Breath Biofeedback mHealth Program: Two-Year Outcomes in Adults With Overweight or Obesity
1 other identifier
observational
11,524
1 country
1
Brief Summary
The goal of this retrospective observational study is to evaluate the real-world durability of weight loss among adults with overweight or obesity who used the Key to Health breath-biofeedback mHealth program. The main questions it aims to answer are:
- 1.What is the mean percent total body weight loss (TBWL%) at 104 weeks after program start?
- 2.What are the TBWL% estimates at 12, 24, and 52 weeks, and what proportion of users achieve clinically meaningful weight loss (≥5% and ≥10%) at 52 and 104 weeks (observed case)?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2018
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 18, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 25, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 25, 2025
CompletedFirst Submitted
Initial submission to the registry
February 17, 2026
CompletedFirst Posted
Study publicly available on registry
February 24, 2026
CompletedFebruary 24, 2026
February 1, 2026
6.4 years
February 17, 2026
February 17, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Percent Total Body Weight Loss (TBWL%) at Week 104.
TBWL% at Week 104 is defined as: (post-baseline weight - baseline weight) / baseline weight × 100, where baseline weight is the self-reported onboarding weight. The Week-104 weight is the post-baseline weight entry closest to Day 728 within the prespecified visit window (Days 668-788; earlier selected if equidistant).
Week 104 (target Day 728; visit window Days 668-788 after program start).
Secondary Outcomes (11)
Percent Total Body Weight Loss (TBWL%) at Week 52
Week 52 (target Day 364; visit window Days 334-394)
Percent Total Body Weight Loss (TBWL%) at Week 24
Week 24 (target Day 168; visit window Days 138-198)
Percent Total Body Weight Loss (TBWL%) at Week 12
Week 12 (target Day 84; visit window Days 69-99)
Proportion Achieving ≥5% Weight Loss at Week 52 (Observed Case)
Week 52 (target Day 364; visit window Days 334-394)
Proportion Achieving ≥10% Weight Loss at Week 52 (Observed Case)
Week 52 (target Day 364; visit window Days 334-394)
- +6 more secondary outcomes
Study Arms (1)
Key to Health Program Users (Commercial Cohort)
Adults with overweight or obesity who enrolled in and used the Key to Health breath-biofeedback mHealth weight-loss program during the data collection window and had a valid onboarding baseline weight plus at least one post-baseline weight entry recorded via the app and/or a connected scale.
Interventions
A breath acetone biofeedback device used alongside the Key to Health mobile app as part of a comprehensive weight-loss program. Users obtain breath acetone readings via the device and record body weight via manual entry and/or connected scale. The app provides program resources to support behavior change, including a food database/food logging tools, nutrition and exercise education (lessons, articles, and other content), alerts/notifications, and engagement features (e.g., streaks and progress tracking). This study retrospectively analyzes de-identified data generated during routine program use; no study-specific procedures are administered.
Eligibility Criteria
Commercial users of the Key to Health digital weight loss program (mobile app) who enrolled and used the program during the data collection window. Users are members of the general community who accessed the program through routine commercial availability (direct-to-consumer), and who recorded weight measurements during typical use of the app and/or a connected scale. De-identified backend program data were used for this retrospective analysis.
You may qualify if:
- Adults aged ≥18 years at program start/onboarding
- Program start date between November 2018 and April 2023
- Valid baseline (onboarding) self-reported weight recorded
- Baseline BMI \>25 kg/m²
- At least one valid post-baseline weight entry recorded after onboarding (manual and/or connected scale)
You may not qualify if:
- Missing or invalid baseline weight
- Biologically implausible baseline weight (per prespecified data-quality checks)
- No post-baseline weight data recorded after the baseline date/onboarding timestamp
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UBC Okanagan
Kelowna, British Columbia, V1V 1V7, Canada
Related Publications (3)
Falkenhain K, Lowe DA, Locke SR, Singer J, Weiss EJ, Little JP. Long-Term Weight Loss in Adults With Overweight or Obesity Using a Breath Biofeedback mHealth App: A One-Year Follow-Up of a Randomized Trial. Obes Sci Pract. 2025 Dec 5;11(6):e70106. doi: 10.1002/osp4.70106. eCollection 2025 Dec.
PMID: 41356752BACKGROUNDFalkenhain K, Locke SR, Lowe DA, Lee T, Singer J, Weiss EJ, Little JP. Use of an mHealth Ketogenic Diet App Intervention and User Behaviors Associated With Weight Loss in Adults With Overweight or Obesity: Secondary Analysis of a Randomized Clinical Trial. JMIR Mhealth Uhealth. 2022 Mar 14;10(3):e33940. doi: 10.2196/33940.
PMID: 35285809BACKGROUNDFalkenhain K, Locke SR, Lowe DA, Reitsma NJ, Lee T, Singer J, Weiss EJ, Little JP. Keyto app and device versus WW app on weight loss and metabolic risk in adults with overweight or obesity: A randomized trial. Obesity (Silver Spring). 2021 Oct;29(10):1606-1614. doi: 10.1002/oby.23242. Epub 2021 Sep 14.
PMID: 34124856BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jonathan Little
UBC Okanagan
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
February 17, 2026
First Posted
February 24, 2026
Study Start
November 18, 2018
Primary Completion
April 25, 2025
Study Completion
April 25, 2025
Last Updated
February 24, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared because the dataset is derived from a commercial digital health program and contains sensitive user-level information. Only de-identified and aggregated results will be reported, and any data sharing would be subject to applicable privacy, consent, and contractual restrictions.